Final Up to date:March 03, 2026, 22:14 IST
The regulatory company suggested docs and healthcare professionals to rigorously prescribe the affected product.
The regulator, within the alert discover, talked about that these r-DNA origin injectables are required to be saved between 2°C and eight°C. (Representational)
India’s drug regulator issued an alert after a consignment of insulin manufactured by French drugmaker Sanofi India was reported stolen, elevating issues about doable improper storage and affected person security, News18 learnt.
In an official communication dated March 2, seen by News18, the Central Medication Commonplace Management Group (CDSCO) mentioned it had been knowledgeable by Sanofi India Restricted concerning the theft of Lantus SoloStar – insulin Glargine injection, particularly its batch quantity 5F0347B.
Insulin glargine is a long-acting basal insulin used within the administration of Sort 1 and Sort 2 diabetes and is prescribed to hundreds of sufferers each day to keep up secure blood glucose ranges. In a rustic referred to as the diabetes capital of the world, the place hundreds of thousands rely upon uninterrupted insulin entry, the integrity of such temperature-sensitive merchandise turns into particularly important.
The regulator, within the alert discover, talked about that these r-DNA origin injectables are required to be saved between 2°C and eight°C.
“The standard of the merchandise could also be compromised if the merchandise usually are not dealt with in correct storage circumstances because the formulations are alleged to be maintained at 2°C to eight°C failing which might affect the standard of the product and in flip affect the security of the sufferers,” the advisory said.
In line with a Sanofi spokesperson, “affected person security is of paramount significance” to the corporate.
“An FIR has already been lodged on this matter. Within the curiosity of transparency, we’re working carefully with CDSCO and different stakeholders to deal with this difficulty. We uphold the best moral requirements in all our operations and endeavours,” the spokesperson mentioned.
The regulatory company suggested docs and healthcare professionals to rigorously prescribe the affected product and educate sufferers to report any “antagonistic drug reactions”. Sufferers and shoppers have been requested to obtain the product solely from approved sources and guarantee correct invoices can be found on the time of buy.
State and UT drug controllers and CDSCO’s zonal and sub-zonal workplaces have been directed to maintain strict vigil on the motion of the mentioned batch available in the market and provoke crucial actions.
The matter is at present below police investigation. The consignment was stolen from Jagmohanpur, Keonjhar Street, Odisha, whereas it was being transported to the corporate’s Kolkata distributor.
Delhi, India, India
March 03, 2026, 22:14 IST
Learn Extra
